Avhana Health, Inc.

Avhana Health, Inc. develops integrated healthcare solutions that enhance clinical workflows and patient engagement within electronic health records, focusing on improving care delivery for healthcare providers. Avhana Health, Inc. was founded in 2014 and is headquartered in Baltimore, US.

The company operates in the healthcare technology sector, providing solutions that integrate with electronic health records. Nathaniel Weiner is the founder, who has a background in healthcare innovation. In January 2021, Avhana Health was acquired by Amalgam RX, Inc. from its investors, including DreamIt Ventures and SR One.

The acquisition terms were not disclosed. The company has completed three deals with its most recent occurring on January 13, 2021. In its latest funding round, a Seed round, Avhana Health raised USD 0. 75 mn with lead investor SR One, among others, bringing the total amount raised to USD 0.

75 mn. Avhana Health, Inc. focuses on integrated point-of-care solutions that work seamlessly within electronic health records (EHR) systems. Their primary offerings include patient identification, clinical trial recruitment, care guidelines, and financial assistance, all aimed at enhancing provider workflows.

These solutions utilize advanced conversational artificial intelligence (AI) to boost patient engagement while complying with strict life sciences regulatory standards. The company primarily serves top life sciences organizations, creating tailored patient support applications and regulated Software as a Medical Device (SaMD) products that contribute to improved health outcomes across various international markets, including North America, Europe, Asia, and parts of South America. Avhana Health generates revenue primarily through partnerships with life sciences companies and healthcare providers, employing a transaction structure that emphasizes the development and deployment of regulated software solutions. Their B2B business model provides subscription-based access to platforms and services that enhance patient care delivery.

Revenue is derived from long-term contracts with healthcare organizations utilizing Avhana's solutions, which may include ongoing support and updates. Clients often engage in multi-year agreements that incorporate initial fees and recurring service costs, aligned with the implementation of their AI-driven applications. Avhana Health plans to expand its offerings and enter new markets following its acquisition by Amalgam RX, Inc. The company is in the process of developing upcoming products that will enhance its EHR integration capabilities.

Additionally, Avhana is targeting expansion into new geographic regions, focusing on markets in Europe and Asia by 2023. The recent Seed funding round will be utilized to support these initiatives, including the design and launch of new healthcare solutions aimed at improving clinical workflows.